Clinical Trial Update: This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

View source ↗

Summary

A retrospective observational study analyzing characteristics and outcomes of participants taking Inflectra (infliximab-dyyb) within the CorEvitas Rheumatoid Ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• INFLECTRA (infliximab-dyyb)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2024-04-12